Journal of hepato-biliary-pancreatic sciences · 2026
Distance From the Root of the Splenic Artery to the Tumor as a Predictor of Para-Aortic Lymph Node Metastasis in Left-Sided Pancreatic Cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kimura Kotaro, Sato Shoki, Naito Zen, Yamamoto Hiroyuki, Suzuki Tomohiro, Kyogoku Noriaki, Katagiri Hirokatsu, Takada Minoru, Ambo Yoshiyasu, Hirano Satoshi
Аннотация
BACKGROUND/PURPOSE: Preoperative diagnosis of para-aortic lymph node (PALN) metastasis, particularly at station 16b1-a contraindication to pancreatic ductal adenocarcinoma (PDAC) resection-remains challenging. We investigated whether the distance from the root of the splenic artery (SPA) to the tumor (DST) is an objective predictor of PALN metastasis.
METHODS: We retrospectively analyzed 130 patients who underwent distal pancreatectomy with PALN sampling for PDAC from 2012 to 2022. DST was measured using preoperative contrast-enhanced computed tomography. Receiver operating characteristic (ROC) analysis was performed, and clinicopathological factors were analyzed.
RESULTS: PALN metastasis occurred in 7/130 (5.4%) patients. DST was significantly shorter in the PALN-positive group (median: 12.0 vs. 18.0 mm, p = 0.0001). ROC analysis indicated that the optimal cutoff value was 20.0 mm. In univariate and multivariate analyses, DST ≤ 20.0 mm was the only factor significantly associated with PALN metastasis (p = 0.0042 and p = 0.0093, respectively). All PALN-positive cases had DST ≤ 20.0 mm.
CONCLUSIONS: DST is a clinically useful metric for predicting PALN metastasis in left-sided PDAC. In patients with DST > 20 mm, the likelihood of PALN involvement appeared extremely low, suggesting that intraoperative lymph node sampling may be omitted in selected patients.
METHODS: We retrospectively analyzed 130 patients who underwent distal pancreatectomy with PALN sampling for PDAC from 2012 to 2022. DST was measured using preoperative contrast-enhanced computed tomography. Receiver operating characteristic (ROC) analysis was performed, and clinicopathological factors were analyzed.
RESULTS: PALN metastasis occurred in 7/130 (5.4%) patients. DST was significantly shorter in the PALN-positive group (median: 12.0 vs. 18.0 mm, p = 0.0001). ROC analysis indicated that the optimal cutoff value was 20.0 mm. In univariate and multivariate analyses, DST ≤ 20.0 mm was the only factor significantly associated with PALN metastasis (p = 0.0042 and p = 0.0093, respectively). All PALN-positive cases had DST ≤ 20.0 mm.
CONCLUSIONS: DST is a clinically useful metric for predicting PALN metastasis in left-sided PDAC. In patients with DST > 20 mm, the likelihood of PALN involvement appeared extremely low, suggesting that intraoperative lymph node sampling may be omitted in selected patients.